Authors:
GIJSMAN HJ
VANGERVEN JMA
TIELEMAN MC
SCHOEMAKER RC
PIETERS MSM
FERRARI MD
COHEN AF
VANKEMPEN GMJ
Citation: Hj. Gijsman et al., PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF ORAL AND INTRAVENOUS META-CHLOROPHENYLPIPERAZINE IN HEALTHY-VOLUNTEERS, Journal of clinical psychopharmacology, 18(4), 1998, pp. 289-295
Authors:
VANHAARST AD
VANTKLOOSTER GAE
VANGERVEN JMA
SCHOEMAKER RC
VANOENE JC
BURGGRAAF J
COENE MC
COHEN AF
Citation: Ad. Vanhaarst et al., THE INFLUENCE OF CISAPRIDE AND CLARITHROMYCIN ON QT INTERVALS IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 542-546
Authors:
DEROODE A
VANGERVEN JMA
COHEN AF
SCHOEMAKER RC
BOVILL JG
Citation: A. Deroode et al., THE EFFECTS OF 2 LEVELS OF MIDAZOLAM (M) AND PROPOFOL (P), USING TARGET-CONTROLLED INFUSION (TCI), ON MEMORY AND SEDATION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 57-57
Authors:
DINGEMANSE J
VANGERVEN JMA
SCHOEMAKER RC
RONCARI G
OBERYE JJL
VANOOSTENBRUGGEN MF
MASSARELLA J
SEGALA P
ZELL M
COHEN AF
Citation: J. Dingemanse et al., INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF RO-48-6791, A NEWBENZODIAZEPINE, IN COMPARISON WITH MIDAZOLAM DURING FIRST ADMINISTRATION TO HEALTHY MALE-SUBJECTS, British journal of clinical pharmacology, 44(5), 1997, pp. 477-486
Authors:
VANGERVEN JMA
RONCARI G
SCHOEMAKER RC
MASSARELLA J
KEESMAAT P
KOOYMAN H
HEIZMANN P
ZELL M
COHEN AF
DINGEMANSE J
Citation: Jma. Vangerven et al., INTEGRATED PHARMACOKINETICS AND PHARMACODYNAMICS OF RO-48-8684, A NEWBENZODIAZEPINE, IN COMPARISON WITH MIDAZOLAM DURING FIRST ADMINISTRATION TO HEALTHY MALE-SUBJECTS, British journal of clinical pharmacology, 44(5), 1997, pp. 487-493
Authors:
VANSTEVENINCK AL
WALLNOFER AE
SCHOEMAKER RC
PIETERS MSM
DANHOF M
VANGERVEN JMA
COHEN AF
Citation: Al. Vansteveninck et al., A STUDY OF THE EFFECTS OF LONG-TERM USE ON INDIVIDUAL SENSITIVITY TO TEMAZEPAM AND LORAZEPAM IN A CLINICAL POPULATION, British journal of clinical pharmacology, 44(3), 1997, pp. 267-275
Authors:
VANGERVEN JMA
SCHOEMAKER RC
JACOBS LD
REINTS A
OUWERSLOOTVANDERMEIJ MJ
HOEDEMAKER HGJ
COHEN AF
Citation: Jma. Vangerven et al., SELF-MEDICATION OF A SINGLE HEADACHE EPISODE WITH KETOPROFEN, IBUPROFEN OR PLACEBO, HOME-MONITORED WITH AN ELECTRONIC PATIENT DIARY, British journal of clinical pharmacology, 42(4), 1996, pp. 475-481
Citation: Jma. Vangerven et Aml. Tjonatsien, THE EFFICACY OF ALDOSE REDUCTASE INHIBITORS IN THE MANAGEMENT OF DIABETIC COMPLICATIONS - COMPARISON WITH INTENSIVE INSULIN-TREATMENT AND PANCREATIC TRANSPLANTATION, Drugs & aging, 6(1), 1995, pp. 9-28
Authors:
VANGERVEN JMA
HOVESTADT A
MOLL JWB
RODENBURG CJ
SPLINTER TAW
VANOOSTEROM AT
KEIZER L
DROGENDIJK TE
GROENHOUT CM
VECHT CJ
NEIJT JP
Citation: Jma. Vangerven et al., THE EFFECTS OF AN ACTH-[4-9] ANALOG ON DEVELOPMENT OF CISPLATIN NEUROPATHY IN TESTICULAR CANCER - A RANDOMIZED TRIAL, Journal of neurology, 241(7), 1994, pp. 432-435
Authors:
VANGERVEN JMA
BOOT JP
LEMKES HHPJ
VANBEST JA
Citation: Jma. Vangerven et al., EFFECTS OF ALDOSE REDUCTASE INHIBITION WITH TOLRESTAT ON DIABETIC-RETINOPATHY IN A 6 MONTHS DOUBLE-BLIND TRIAL, Documenta ophthalmologica, 87(4), 1994, pp. 355-365
Citation: Jma. Vangerven, FURTHER CLINICAL-STUDIES WITH AN ALDOSE REDUCTASE INHIBITOR IN DIABETIC NEUROPATHY, Diabetic medicine, 10(5), 1993, pp. 35-38